ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bousquet, J.
Right arrow Articles by Khaltaev, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bousquet, J.
Right arrow Articles by Khaltaev, N.
Eur Respir J 2007; 29:233-239
Copyright ©ERS Journals Ltd 2007

Global Alliance against Chronic Respiratory Diseases

J. Bousquet1, R. Dahl2 and N. Khaltaev3

1 Hôpital Arnaude de Villeneuve, CHU Montpellier, Montpellier, France, 2 Aarhus University Hospital, Aarhus, Denmark, 3 World Health Organization, Geneva, Switzerland.

CORRESPONDENCE: N. Khaltaev, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. Fax: 41 227914766. E-mail: khaltaevn{at}who.ch

Keywords: Asthma, chronic obstructive pulmonary disease, chronic respiratory diseases, World Health Organization

Received: October 25, 2006
Accepted November 10, 2006

Hundreds of millions of people of all ages suffer from chronic respiratory diseases which include asthma and respiratory allergies, chronic obstructive pulmonary disease, occupational lung diseases and pulmonary hypertension. More than 500 million patients live in developing countries or in deprived populations. Chronic respiratory diseases are increasing in prevalence. Although the cost of inaction is clear and unacceptable, chronic respiratory diseases and their risk factors receive insufficient attention from the healthcare community, government officials, media, patients and families. The Fifty-Third World Health Assembly recognised the enormous human suffering caused by chronic diseases and requested the World Health Organization (WHO) Director General to give priority to the prevention and control of chronic diseases, with special emphasis on developing countries. This led to the formation of the WHO Global Alliance against Chronic Respiratory Diseases (GARD). GARD is a voluntary alliance of organisations, institutions and agencies working towards a common vision to improve global lung health according to local needs. GARD is developed in a stepwise approach using the following three planning steps: estimate population need and advocate action; formulate and adopt policy; and identify policy implementation steps.




This article has been cited by other articles:


Home page
Eur Respir JHome page
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi
Definition, epidemiology and natural history of COPD
Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Humbert
The burden of pulmonary hypertension
Eur. Respir. J., July 1, 2007; 30(1): 1 - 2.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.